Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review

Abstract Background Breast cancer (BC) continues to be a significant global health issue, with a rising number of cases requiring ongoing research and innovation in treatment strategies. Curcumin (CUR), a natural compound derived from Curcuma longa, and similar compounds have shown potential in targ...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryam Golmohammadi, Mohammad Yassin Zamanian, Ahmed Muzahem Al‐Ani, Thaer L. Jabbar, Ali Kamil Kareem, Zeinab Hashem Aghaei, Hossein Tahernia, Ahmed Hjazi, Saad Abdul‐ridh Jissir, Elham Hakimizadeh
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Animal Models and Experimental Medicine
Subjects:
Online Access:https://doi.org/10.1002/ame2.12491
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846101931741675520
author Maryam Golmohammadi
Mohammad Yassin Zamanian
Ahmed Muzahem Al‐Ani
Thaer L. Jabbar
Ali Kamil Kareem
Zeinab Hashem Aghaei
Hossein Tahernia
Ahmed Hjazi
Saad Abdul‐ridh Jissir
Elham Hakimizadeh
author_facet Maryam Golmohammadi
Mohammad Yassin Zamanian
Ahmed Muzahem Al‐Ani
Thaer L. Jabbar
Ali Kamil Kareem
Zeinab Hashem Aghaei
Hossein Tahernia
Ahmed Hjazi
Saad Abdul‐ridh Jissir
Elham Hakimizadeh
author_sort Maryam Golmohammadi
collection DOAJ
description Abstract Background Breast cancer (BC) continues to be a significant global health issue, with a rising number of cases requiring ongoing research and innovation in treatment strategies. Curcumin (CUR), a natural compound derived from Curcuma longa, and similar compounds have shown potential in targeting the STAT3 signaling pathway, which plays a crucial role in BC progression. Aims The aim of this study was to investigate the effects of curcumin and its analogues on BC based on cellular and molecular mechanisms. Materials & Methods The literature search conducted for this study involved utilizing the Scopus, ScienceDirect, PubMed, and Google Scholar databases in order to identify pertinent articles. Results This narrative review explores the potential of CUR and similar compounds in inhibiting STAT3 activation, thereby suppressing the proliferation of cancer cells, inducing apoptosis, and inhibiting metastasis. The review demonstrates that CUR directly inhibits the phosphorylation of STAT3, preventing its movement into the nucleus and its ability to bind to DNA, thereby hindering the survival and proliferation of cancer cells. CUR also enhances the effectiveness of other therapeutic agents and modulates the tumor microenvironment by affecting tumor‐associated macrophages (TAMs). CUR analogues, such as hydrazinocurcumin (HC), FLLL11, FLLL12, and GO‐Y030, show improved bioavailability and potency in inhibiting STAT3, resulting in reduced cell proliferation and increased apoptosis. Conclusion CUR and its analogues hold promise as effective adjuvant treatments for BC by targeting the STAT3 signaling pathway. These compounds provide new insights into the mechanisms of action of CUR and its potential to enhance the effectiveness of BC therapies.
format Article
id doaj-art-78eb667bbef84143ab5dea16cc7bff8f
institution Kabale University
issn 2576-2095
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Animal Models and Experimental Medicine
spelling doaj-art-78eb667bbef84143ab5dea16cc7bff8f2024-12-28T05:24:15ZengWileyAnimal Models and Experimental Medicine2576-20952024-12-017685386710.1002/ame2.12491Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative reviewMaryam Golmohammadi0Mohammad Yassin Zamanian1Ahmed Muzahem Al‐Ani2Thaer L. Jabbar3Ali Kamil Kareem4Zeinab Hashem Aghaei5Hossein Tahernia6Ahmed Hjazi7Saad Abdul‐ridh Jissir8Elham Hakimizadeh9School of Medicine Shahid Beheshti University of Medical Sciences Tehran IranDepartment of Physiology, School of Medicine Hamadan University of Medical Sciences Hamadan IranDepartment of Medical Laboratories Technology AL‐Nisour University College Baghdad IraqCollege of pharmacy Al‐ Ayen University Nasiriyah IraqBiomedical Engineering Department Al‐Mustaqbal University College Hillah IraqPreventative Gynecology Research Center Shahid Beheshti University of Medical Sciences Tehran IranMolecular Medicine Research Center, Research Institute of Basic Medical Sciences Rafsanjan University of Medical Sciences Rafsanjan IranDepartment of Medical Laboratory Sciences, College of Applied Medical Sciences Prince Sattam bin Abdulaziz University Al‐Kharj Saudi ArabiaCollege of Nursing Al‐Bayan University Baghdad IraqPhysiology‐Pharmacology Research Center, Research Institute of Basic Medical Sciences Rafsanjan University of Medical Sciences Rafsanjan IranAbstract Background Breast cancer (BC) continues to be a significant global health issue, with a rising number of cases requiring ongoing research and innovation in treatment strategies. Curcumin (CUR), a natural compound derived from Curcuma longa, and similar compounds have shown potential in targeting the STAT3 signaling pathway, which plays a crucial role in BC progression. Aims The aim of this study was to investigate the effects of curcumin and its analogues on BC based on cellular and molecular mechanisms. Materials & Methods The literature search conducted for this study involved utilizing the Scopus, ScienceDirect, PubMed, and Google Scholar databases in order to identify pertinent articles. Results This narrative review explores the potential of CUR and similar compounds in inhibiting STAT3 activation, thereby suppressing the proliferation of cancer cells, inducing apoptosis, and inhibiting metastasis. The review demonstrates that CUR directly inhibits the phosphorylation of STAT3, preventing its movement into the nucleus and its ability to bind to DNA, thereby hindering the survival and proliferation of cancer cells. CUR also enhances the effectiveness of other therapeutic agents and modulates the tumor microenvironment by affecting tumor‐associated macrophages (TAMs). CUR analogues, such as hydrazinocurcumin (HC), FLLL11, FLLL12, and GO‐Y030, show improved bioavailability and potency in inhibiting STAT3, resulting in reduced cell proliferation and increased apoptosis. Conclusion CUR and its analogues hold promise as effective adjuvant treatments for BC by targeting the STAT3 signaling pathway. These compounds provide new insights into the mechanisms of action of CUR and its potential to enhance the effectiveness of BC therapies.https://doi.org/10.1002/ame2.12491apoptosiscell proliferationcurcumincurcumin analoguesSTAT3
spellingShingle Maryam Golmohammadi
Mohammad Yassin Zamanian
Ahmed Muzahem Al‐Ani
Thaer L. Jabbar
Ali Kamil Kareem
Zeinab Hashem Aghaei
Hossein Tahernia
Ahmed Hjazi
Saad Abdul‐ridh Jissir
Elham Hakimizadeh
Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
Animal Models and Experimental Medicine
apoptosis
cell proliferation
curcumin
curcumin analogues
STAT3
title Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
title_full Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
title_fullStr Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
title_full_unstemmed Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
title_short Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review
title_sort targeting stat3 signaling pathway by curcumin and its analogues for breast cancer a narrative review
topic apoptosis
cell proliferation
curcumin
curcumin analogues
STAT3
url https://doi.org/10.1002/ame2.12491
work_keys_str_mv AT maryamgolmohammadi targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT mohammadyassinzamanian targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT ahmedmuzahemalani targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT thaerljabbar targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT alikamilkareem targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT zeinabhashemaghaei targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT hosseintahernia targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT ahmedhjazi targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT saadabdulridhjissir targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview
AT elhamhakimizadeh targetingstat3signalingpathwaybycurcuminanditsanaloguesforbreastcanceranarrativereview